Mexico Psoriasis Drug Market Size & Outlook, 2025-2033

Mexico Psoriasis Drug Market Insights

As per Reed Intelligence insights, the Mexico Psoriasis Drug Market stood at USD 255.51 Million in 2024 and is anticipated to grow to USD 699.59 Million by 2033.
The Mexico market is expected to advance at a CAGR of 11.76% from 2026 through 2033.
In 2024, Biologics accounted for the highest share of the By Drug Class market size.
During the forecast period, Biologics is set to register the highest growth, making it the most lucrative By Drug Class segment.

Other Key Findings

Mexico contributed 2.07% to the global Psoriasis Drug Market size in 2024.
By 2033, United States is forecasted to remain the largest global market for Psoriasis Drug Market.
In LATAM, Brazil is projected to capture the leading share of market size by 2033.
Among LATAM markets, Brazil is expected to post the fastest growth, reaching USD 925.54 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 255.51 Million
Market Size In 2033	USD 699.59 Million
Largest segment	Biologics
Units	Revenue in USD Million
CAGR	11.76% (2025-2033)
Segmnetation Covered
By Drug Class	Biologics Corticosteroids Vitamin D Analogs Others
By Therapeutic Class	Tumour Necrosis Factor (TNF) Phosphodiesterase Type 4 (PDE4) Interleukin Others
By Route of Administration	Oral Parenteral Topical
By Distribution Chanel	Hospital Pharmacies Retail Pharmacies E-commerce Others
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Mexico Psoriasis Drug Market By Drug Class 2025-2033 (USD Million)

By Drug Class	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Biologics	XX.x	XX.x	XX.x	110.38	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Corticosteroids	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Vitamin D Analogs	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Psoriasis Drug Market By Therapeutic Class 2025-2033 (USD Million)

By Therapeutic Class	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Tumour Necrosis Factor (TNF)	XX.x	XX.x	XX.x	102.59	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Phosphodiesterase Type 4 (PDE4)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Interleukin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Psoriasis Drug Market By Route of Administration 2025-2033 (USD Million)

By Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	116.46	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Parenteral	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Topical	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Mexico Psoriasis Drug Market By Distribution Chanel 2025-2033 (USD Million)

By Distribution Chanel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospital Pharmacies	XX.x	XX.x	XX.x	113.73	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Retail Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
E-commerce	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.